Updated Risk Assessment of Cannabidiol in Foods Based on Benchmark Dose–Response Modeling
Abstract Cannabidiol (CBD), a non-psychotropic main component of the Cannabis plant, has been approved as a drug in the European…
benchmark dose
Perinatal Tetrahydrocannabinol Compromises Maternal Care and Increases Litter Attrition in the Long–Evans Rat
Abstract The marijuana legalization trend in the U.S. will likely lead to increased use by younger adults during gestation and…
Specific phosphorylation of microtubule-associated protein 2c by extracellular signal–regulated kinase reduces interactions at its Pro-rich regions
Abstract Microtubule-associated protein 2 (MAP2) is an important neuronal target of extracellular signal–regulated kinase 2 (ERK2) involved in Raf signaling…
A Scoping Review on Clinical Trials of Pain Reduction With Cannabis Administration in Adults
Abstract Indications of cannabis use are numerous although the indication to relief pain remains a major research interest and clinical…
Dosage, Efficacy and Safety of Cannabidiol Administration in Adults: A Systematic Review of Human Trials
Abstract Considering data from in vitro and in vivo studies, cannabidiol (CBD) seems to be a promising candidate for the…